Sienna Biopharmaceuticals Inc. (SNNAQ)

[420man]

Delist Friday...wondering if the Q will be added as well...


Back to News Results
Sienna Biopharmaceuticals Will Be Delisted from Nasdaq -- Market Talk

11:57 am ET December 11, 2019 (Dow Jones) Print
1157 ET - Sienna Biopharmaceuticals has requested that Nasdaq delist the company's stock as of Friday. The clinical-stage biopharmaceutical company, which went public in 2017 and filed for chapter 11 bankruptcy protection in September, said Tuesday it will shut down by the end of the week. Sienna's stock was to remain conditionally listed on the Nasdaq pending the results of a sale process, which resulted in Sienna receiving approval to sell one of its topical medications to Sebacia Inc, a commercial-stage dermatology and aesthetics company, for about $1.7M. The company did not receive bids for any of its other assets. ([e-mail]; @aishaalmuslim)

(END) Dow Jones Newswires

December 11, 2019 11:57 ET (16:57 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.